• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » The CenterWatch Weekly, June 05, 2017

The CenterWatch Weekly, June 05, 2017

June 5, 2017
CenterWatch Staff

Is cannabis poised to disrupt the pharma industry? Many say yes.

Is cannabis—now legal in many states—set to enter mainstream research and development, possibly taking over pain control where opioids left off in the market? Or seizure disorders? Severe nausea? Glaucoma? Many researchers are working to bring cannabis and cannabinoids into the mainstream medicine chest. Others feel that cannabis is such a different animal, with so much baggage, that the roadblocks it faces to becoming an accepted medicine in the U.S. may be, for the time being, insurmountable.

ERT and Orbita collaborate to improve patient retention and trial efficiency

Mobile health applications have transformed the way many people approach their health. Applications can now track food and nutrition intake, activity levels and even sleep habits. Similar health applications have also permeated clinical research; in fact, there has been an increased demand for and utilization of mobile health applications for data capture during clinical trials. This form of data capture is aimed at streamlining the data procurement process, ultimately improving the time in which results from a trial can be analyzed and interpreted.

 

To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing